Media Library

Highlights of Expert Commentary of OFS
In this final video, Polly Niravath, MD, Abbey Kaler, APRN, FNP-C, CMSRN, and Emily Beard, RN, BSN, OCN, CBCN, CG, discuss the clinical features of premenopausal women with breast cancer who may be suitable for treatment with ovarian function suppression (OFS) therapy, effective use of OFS therapy, and relevant navigation strategies used to address the potential challenges associated with OFS treatment. View Video ›

Managing Clinical and Psychosocial Impacts of OFS
Hear expert commentary on ovarian function suppression (OFS) side effect management, including strategies used to address psychosocial challenges affecting premenopausal breast cancer patients undergoing OFS. View Video ›

Fertility Preservation and Benefits of OFS
Polly Niravath, MD, discusses fertility preservation in premenopausal women with breast cancer who are undergoing ovarian function suppression (OFS) treatment. View Video ›

Setting Patient Expectations of OFS Treatment
Listen as a nurse navigator discusses ovarian function suppression (OFS) and the subsequent impact of OFS on premenopausal women with breast cancer. View Video ›

Guillermo Garcia-Manero, MD, from MD Anderson Cancer Center, characterizes the clinical outcome improvements observed with luspatercept for lower-risk myelodysplastic syndromes in clinical practice. View Video ›

Guillermo Garcia-Manero, MD, from MD Anderson Cancer Center, explores imetelstat trial results of patients with transfusion-dependent lower-risk myelodysplastic syndromes who experience failure to or are ineligible for treatment with erythropoiesis-stimulating agents. View Video ›

Guillermo Garcia-Manero, MD, from MD Anderson Cancer Center, explores imetelstat trial results of patients with transfusion-dependent lower-risk myelodysplastic syndromes who experience failure to or are ineligible for treatment with erythropoiesis-stimulating agents. View Video ›

Please join Guillermo Garcia-Manero, MD, from MD Anderson Cancer Center, as he discusses how the clinical benefits of luspatercept could lead to a new standard of care for patients with transfusion-dependent lower-risk myelodysplastic syndromes. View Video ›

Helping Patients with Multiple Myeloma Comply with Their Therapy Requires a Team Approach
Successfully getting patients with multiple myeloma to follow their therapy regimen often requires a team approach. Please join Charise Gleason, MSN, NP-C, AOCNP, and Nikki Barkett, RN, BSN, OCN, as they outline which team members they utilize and how they use this technique at their institutions. View Video ›

Accumulating Adverse Events May Cause Patients with Multiple Myeloma to Be Reluctant to Adhere to Their Treatment Plan
Charise Gleason, MSN, NP-C, AOCNP, and Nikki Barkett, RN, BSN, OCN, discuss how they use shared decision-making with patients to help them remain adherent to their treatment plan. View Video ›

Page 1 of 12


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: